Front Barnett Associates LLC Eli Lilly & CO Transaction History

Front Barnett Associates LLC

$833 Million
Q3 2023

A detailed history of Front Barnett Associates LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Front Barnett Associates LLC holds 3,255 shares of LLY stock, worth $2.59 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

3,255

Previous 3,255 -0.0%

Holding current value

$2.59 Million

Previous $1.53 Million 14.47%

% of portfolio

0.21%

Previous 0.17%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $35,074 - $46,898	100 Added 3.17%	3,255 $1.53 Million
Q1 2023 May 08, 2023	SELL	$310.63 - $364.82 $1,242 - $1,459	-4 Reduced 0.13%	3,155 $1.08 Million
Q4 2022 Feb 06, 2023	SELL	$321.55 - $374.67 $8,038 - $9,366	-25 Reduced 0.79%	3,159 $1.16 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $5,574 - $6,545	-20 Reduced 0.62%	3,184 $1.03 Million
Q1 2022 May 11, 2022	BUY	$234.69 - $291.66 $938 - $1,166	4 Added 0.13%	3,204 $918,000
Q4 2021 Feb 08, 2022	SELL	$224.85 - $279.04 $23,609 - $29,299	-105 Reduced 3.18%	3,200 $884,000
Q2 2021 Aug 18, 2021	SELL	$180.55 - $233.54 $18,055 - $23,354	-100 Reduced 2.94%	3,305 $759,000
Q4 2019 Feb 12, 2020	SELL	$106.92 - $132.43 $3,742 - $4,635	-35 Reduced 1.02%	3,405 $448,000
Q2 2019 Aug 06, 2019	SELL	$110.79 - $129.32 $7,201 - $8,405	-65 Reduced 1.85%	3,440 $381,000
Q1 2019 May 07, 2019	SELL	$111.31 - $131.02 $2,782 - $3,275	-25 Reduced 0.71%	3,505 $455,000
Q2 2018 Aug 08, 2018	SELL	$75.7 - $86.88 $4,163 - $4,778	-55 Reduced 1.53%	3,530 $301,000
Q1 2018 May 07, 2018	SELL	$74.21 - $87.6 $6,159 - $7,270	-83 Reduced 2.26%	3,585 $277,000
Q3 2017 Nov 07, 2017	BUY	$77.07 - $85.54 $282,692 - $313,760	3,668	3,668 $314,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Front Barnett Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Front Barnett Associates LLC with notifications on news.

Account

Front Barnett Associates LLC Eli Lilly & CO Transaction History